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Glucose molecules are joined to protein molecules to form long-term control of blood sugar., Another new test. the stable ketoamines, or fructosamines, through glycation, a measurement of glycated albumin or glycated total proteins,, , nonenzymatic mechanism involving a labile Schiff base intercommonly referred to as the fructosamine assay, may be mediate and the Amadori rearrangement. The amount of used in a manner analogous to the determination of glycatfructosamine in serum is increased in diabetes mellitus owing ed hemoglobin as an index to the mean concentration of to the abnormally high concentration of sugar in blood. The glucose in blood during the preceding several weeks. As vet, concentration of fructosamine in serum thus reflects the the fructosamine assay is not widely or routinely useddegree of glycemic control attained by the diabetic patient hence, in this review, I describe protein glycation, trace the • and is useful in monitoring the effectiveness of therapy in development of the fructosamine procedure's, compare and diabetes over a period of several weeks, in a manner contrast the various analytical methodologies that have % analogous to the determination of glycated hemoglobin. Of been applied to the assay, and examine the clinical usefulthe analytical approaches used to measure fructosamine, ness of the test. tafnticmaoahs w th menophenybronic aiand Nomenclature. The term 'Tructosamine" in this review affinity chromatography with m-aminophenylboronic acid and refers to glycated albumin and protein, which have been thentroblue tetrazoliumreductionmethodappeartobethe abbreviated in the literature as GSA or GPA (glycated S most practical means for clinical chemists to assay fructosaserum or plasma albumin) and GSP or GPP (glycated serum mine quickly, economically, and accurately. Fructosamine or plasma protein). The term "glycation" is recommended by values can readily distinguish normal individuals and diabetic the IUPAC-IUB Joint Commission on Biochemical Nomenpatients in good glycemic control from diabetics in poor clature for any reaction linking a sugar to a protein (I1 control. Unlike glycated hemoglobin, which reflects the averThus "glycated" protein is preferable to "glycosylated" or age blood sugar concentration over the past six to eight "glucosylated" protein, although both of these terms are weeks, fructosamine reflects the average blood sugar concommon in the literature. Johnson et al. (2) introduced centration over the past two to three weeks. Thus a clinical fructosamine into the clinical chemistry literature in 1982 advantage is that fructosamine responds more quickly to as a general term for glycated protein. Because fructosachanges in therapy, thereby allowing for improved glycemic mine seems to have been generally accepted in the field and control. Used in conjunction with determinations of blood because it is less cumbersome than "glycated serum protein"
.. 7*11 sugar and (or) of glycated hemoglobin, or by itself, the or similar phrases and less ambiguous than an abbreviafructosamine assay can provide clinically useful information tion, I use it preferentially in this paper and interchangefor the detection and contrQi of diabetes. ¥ , iw ably with glycated albumin and glycated protein.
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Fructosamine is the trivial name for I-amino-I-deoxvAdditional Keyphrases: diabetes chromatography, affinrtose, also called isoglucosamine by Emil Fischer. who Ity -nitroblue tetrazolium ' first synthesized the compound in 1886 (3, 4). More broadly. 'tN11 a fructosamine is a ketoamine, a derivative of the nonenzyIntroduction matic reaction product of a sugar (usually glucose) and a protein (usually albumin). As noted, the terms glycated Diabetes affects about 5'4 of the American population and albumin or protein are commonly used in the literature and is the fifth leading cause of death in the United States.
are examples of fructosamines. In contrast, a glycoprotein is Fortunately, early detection and improved therapeutic regia protein molecule, typically a globulin, that contains a mens allow diabetic patients to lead normal lives, and lifecarbohydrate moiety, which was incorporated enzymatically expectancy figures have increased. Clinical chemistry plays during the synthesis of the molecule. The fructosamines an integral role in the diagnosis and treatment of diabetes.
arise from a post-translational modification involving a The determination of blood glucose is the sine qua non for nonenzymatic mechanism and should not be confused with both detection and therapy. The assay of glycated hemoglothe glycoproteins. bin, or Hb Al, specifically, is a fairly recently developed test;
Chemistry ofglvcation. Maillard was the first to describe it is now accepted and used as a means of monitoring the the reaction of amino acids and reducing sugars to fbrm
The nonenzymatic glycation of hemoglobin having been stable ketoamine adducts (5). The Maillard reaction is established and shown to be significantly increased in responsible for the "browning" phenomenon that occurs in diabetes, it was logical to ask whether this was a phenomemilk and other food products 16-91. When milk and other non common to other proteinsi as well. Not surprisingly. foods are heated, carbonyl groups of sugars combine with many proteins have been slhown to he subject to glvcat ion, the amino groups of proteins to form aldimines (Schiff and these findings are often relevant to the complications bases), which progress to stable ketoamines ifructosaminesi: associated with diabetes. Fable 1 summarizes the proteins 5 further reactions result in poorly soluble brown products, other than albumin and the common proteins fbund in the The labile aldimine-Schiff base intermediates undergo the blood that undergo glycation. In 1979 glycated rat and Amadori rearrangement ithe isomerization of an aldosylahuman albumin were prepared in vitro, and gl.,'cated albumine to a 1-amino-l-deoxy-2-ketose) to form the stable min was fbund to be naturally occurring in both species ,59 fructosamine 110. 11). The straight-chain fructosamine, if 62). Albumin was fbund to be glycated at nmultiple sites and formed from giucose. is thought to undergo cvclization to a primarily at the epsilon-amino groups of lysine residues, as hemiketal furanose or pyranose ring structure for added is the case with henglohbin 63. GlycariOri of.lluil, ,od nd stability (12) (13) (14) .
other plasma proteins is increased in diabetes as compared Figure 1 shows the reaction scheme for glucose and a with normal subjects. and the measurement offructosamine protein, with the formation of fructosamine.
correlates Figure 2 . Each ofthese will now be described. with the N-terminal valine of hemoglobin beta chains to with special emphasis on those that ha\'k i,tUnd fivor in the form 1-deoxy-l-(N-valv)-fructose through the Amadori reclinical laboratory. arrangement. Hemoglobin glycation occurs not only at the S valine residues of the beta chain termini but also nonspecifiPhenylhydrazine Procedure . cally at the epsilon amino groups oflysines alor~g the alpha Acharva and Manning (7,. after preparing a stable and beta chains and at the N-termini of the alpha chains ketoamine from glyceraldehvde and hemoglobin A. reacted (18, 19) . Hemoglobin reacts with glucose and other sugars, this fructosamine with phenylhvdrazine. The resulting but also with aldehydes such as formaldehyde, acetaldephenylhydrazone adduct had an absorption maximum at hyde, and glyceraldehyde ( 13, 201 To improve accuracy. investigators hae introduced a . chromatography t("GI c-aflin": Isolab, Akron, 011) was evaldialysis step to remove free glucose. which falsely increases uated by Yatscoff et al. 171 , in a study of diabetic patients results, and the use of a specimn' blank, m which fructosaand normal subjects. Within-run ('Vs were • 6.5'e for both mine is reduced with NalBil, (66. 79). 8 0 ' As an alternative glycated albumin and glycated protein: day-to-day ('Vs to the 12-to 24-h dialysis step to remove endogenous were 7.7' Ior albumin and 14.4' for protein for normal glucose, one ca!i precipitate the proteins, including fructosasubjects and 10.5'" and 17. albumin and protein in serum were significantly higher P hydrolysis with acetic acid yields higher absorbances than <0.001) in diabetic than in nondiabetic dogs and that the does hvdrolvsis with oxalic acid. Ney et al. ,8.11 proposed concentrations of both analytes were similar when nondiaoptimal, standardized conditions that include hydrolysis at 0 , betic and well-controlled diabetic dogs were compared.
115 C in an oil bath for 8 h, a 50-mir incubation with TBA, Could et al. (73i evaluated the affinity-column method used and glycated albumin standards. Elder and Kennedy 1851 in another commercially available phenylboronic acid gel suggested three modifications to optinize the assay: 1a) kit ("Glycogel": Pierce Chemical Co., Rockford, IL). This kit incubating the serum blanks with NaBH for only 15 min. discriminated between normal subjects and diabetic paib)performing the hydrolysis step in an autoclaveat 121 (', tients, exhibited good precision (CVs of 4-6,), and results and (ci using fructose rather than IIMF standards. These correlated with those by the thiobarbituric acid method (r changes decrease the analysis time to about 2-5 h instead of' 0.70). Leiper et al. (74) also prepared aminophenylboronic 10 h, starting with dialyzed serum. The TBA assay has been acid affinity columns containing Glycogel to measure fructoadapted to the Technicon AutoAnalyzer 11 as a semi-autosamine in pregnant diabetics. Within-run CVs of 6.13 or mated method 186, 87). less were obtained for both glycated albumin and protein in Clearly, the TBA method has undergone considerable both diabetic and normal sampleb. Rendell et al. (75, 76 ) also development with a number of variations extant. Its major assessed Glycogel affinity columns and found the method to drawbacks are the typically long analysis time and the have several advantages over the thiobarbituric acid methnumber of steps involved. Dialysis of specimens or protein od. Affinity chromatography appears to be simple and to precipitation to remove interfering endogenous glucose, give reasonably reproducible results, but is not yet widely preparation of Nal{ 1 -reduced serum blanks, the hydroly sis used in clinical laboratories, step, and the long incubation with TBA combine to make it A related assay for glycated albumin, also based upon a labor-and time-intensive procedure. To measure glycated complex formation between the ciN-diol groups of'sugars and albumin specifically. it must be separated from the other , phenvlboronic acid, has been developed by Ilavashi and serum proteins. further complicating the procedure. The use % Makino 77). Serum is mixed with a solution of N-(5-of a molecular exclusion column to remove endogenous dimethyhammino-l-naphthalenesulonvyl-3-aminobenzeneboglucose from samples in lieu of a dialysis or proteinronic acid 'dansylated phenylboronic acidl. The mixture is precipitation step might simplify and speed up tie Lest, '011t excited at 330 nm. 2)) C. and fluorescence emission is this alternative has not been reported in the literature. The measured at 490 nm.
interassav CVs that have been reported. 1.2-13' , indicate %.
2-Thiobarbituic Acid (TBA) Colormetric Procedure that even as a manual procedure the TBA assay is capable of good precision. However, the TBA procedure appears to Gottschalk 3 ' first discovered that treating fructosamines have been by-and-large supplanted by the nitroblue tetrazowith acid yields 5-hydrxymethylfurturaldehyde I IMFI.
ium assay. . has been to react HMF with using "high-performance" liquid chromatogr'aphy rather T1A to firm a derivative that has an absorbance maximum than colorimet'y. Their reversed-phase system uses a sodiat 443 nm. The TIBA procedure had been used in the um acetate (5 g L, pH 4.31 mobile phase and ultraviolet analysis fir tlb A, and was subsequently adapted fior the detection (280 rin), Little et al. 891 have developed a assay of fructosamine i 16. ,591. Early assays typically inmethod for estimating glycated whole-blood proteins Oleuovolved reacting a purified alhumin solution, serum, or globin and phasma proteins, by using capillary blood collectplasma with acetic or oxalic acid for 18-24 h at about 100 C ed and stored on filter paper. This novel approach is to hydrolyze fructosamine and convert it to HMF; after primarily a measure of glycated hemoglobin and involves trichloroacetic acid T('A was added to precipitate the use of a TBA method originally designed fior-analysis of' protein, the supernatant fluid was reacted with TBA at glycated hemoglobin 9t). 
such as glucose and N-glucosylamine serum that reduce NBT during the first 10 min ofthe assay derivatives of labile Schiff bases (3, 7-9 ). In the NBT assay, (103. 104. 1071. However, the assay has been adapted to a serum sample is added to carbonate buffer (at basic pH, analyzers in which incubation times are only 7-8 min; originally pH 10.8, and 37 'C containing NBT, which is performance is claimed to be acceptable. allowing for instrusubsequently reduced; the absorbance at 530 nm is meament-specific reference ranges (106, 108. 109). sured 10 and 15 min later (2). The exact mechanism of the The TBA assay *ias been used to measure glycated reduction of NBT by fructosamine is not known, but recentalbumin, total glycated protein, or both, whereas the NBT ly Jones et al. t92) have presented evidence that it involves a assay was originally designed to measure total glycated superoxide radical intermediate. purified albumin from diabetic patients and found that the albumin was originally used for a standard. The 10-min concentration of glycated albumin was correlated with the incubation is necessary to allow fast-reacting interfering concentration of total glycated plasma protein. Albumin reducing substances to react. Because glucose reduces NBT accounts for about 50% of total plasma protein; apparently, at a pH above 11, but does not react between pH 10.5-11, it is not necessary to measure glycated albumin specifically there is no need to remove endogenous glucose from pabecause total plasma fructosamine reflects glycated albutients' specimens. However, albumin does contribute to the min, and both correlate with the average concentrations of absorbance at 530 rim. fructosamine activity due to the albumin in the standard.
are very acceptable, typically in the range 2-7'?. and an .
The next modification of the assay was the development of interlaboratory CV of 5.4'7 has been reported for a sixglycated protein secondary standards in a bovine albumin month study of 33 laboratories in which five different -_ matrix (40 gL) instead of a DMF primary standard in analyzers and the manual procedure were used (112) . Using human serum albumin t99i. The secondary standards the Cobas Bio, Baker et al. examined 28 potential interferproved to be less variable with changes in reaction condients; interference was notable only from bilirubin, EDTA. tions, resulting in greater accuracy and better reproducibiliheparin, cysteine, and urate (99). When the same interfer-_ ty. San-Gil et al. 10 lO. 101, observing that reducing activients were tested in the RA-1000 version of this procedure. ties of human serum-based DMF standards differed fron heparin, bilirubin, hemoglobin, cysteine. and glutathione , -those of albumin-based standards, recommended the use of interfered, indicating that interference problems vary from serum-based standards. However, this position has been analyzer to analyzer (115) . Hyperlipidemia is common in -disputed by Johnson and Baker (102) . who found that the diabetes, particularly in Type II diabetes, but hypertriglyketoamines in serum have five to six times the reducing ceridemia has been reported not to interfere significantly activity of albumin-based DMF standards. This observation with the validity of fructosamine measurements in diabetic explains why NBT fructosamine values in serum are greatsubjects 116). The occurrence of in vitro glycation after the % er than both the expected concentration of glycated proteins sample has been obtained does not appear to be a problem and the concentrations measured in serum by other glycated with the NBT assay, at least when specimens are kept for 24 % protein assays (e.g., TBA, furosine) (103 albumin solution for standardization of the assay but later challenged the effectiveness of the NBT assay in distinchanged to secondary standards of glycated bovine albumin guishing normals from diabetics; however, the weight of the (40 gL in isotonic saline), which had been calibrated by evidence in the literature overwhelmingly shows that, if using the DMFhuman albumin primary standard. As noted used properly, the NBT fructosamine test is useful for previously. San-Gil et al. 
Protein Glycation in Diabetes Mellitus
assay correlates not only with the concentrations of blood A variety of proteins are subject to nonenzymatic glycaglucose and glycated hemoglobin but also with glycated tion. The amount of glycated protein is increased in diabetes protein as determined by the TBA and affinity chromatogramellitus and is thought to contribute to the long-term phy methods (2, 95. 96, 99-104, 107-111. 119 . 151). complications of the disease (125-129) , e.g., through enzyme How does fructosamine analysis compare to the measureinactivation, inhibition of binding of regulatory molecules, ment of blood glucose and glycated hemoglobin in terms of decreased proteolysis, and the crosslinking of glycated proclinical usefulness? The half-life of hemoglobin is about 60 teins and the trapping of soluble proteins by glycated days. that of albumin about 14-20 days, and that of various proteins (129). Glycated proteins (summarized in Table 1) other proteins. 2.5-23 days 159, 147. 148). Fructosamine are typically increased in diabetes. The concentrations of reflects the mean glucose concentration in blood over a glycoproteins, such as haptoglobin and fibrinogen, are also period of about two to three weeks while the Hb A 1 , .
increased in diabetes, but glycoprotein synthesis results concentration is indicative of the concentration of blood from the activity of glycosyltransferases and should not be sugar over a six-to eight-week period. In a study of rabbits confused with synthesis offructosamines, which result from made diabetic by administration of alloxan, Rendell et al. nonenzymatic glycation (130-138) .
(76). using affinity chromatography, found that the cuncenMeasurement of glycated hemoglobin, Hb Al,, has proven tration of glycated albumin plateaued four weeks after to be particularly useful in monitoring the effectiveness of alloxan administration, while concentrations of glycated therapy in diabetes, reflecting the long-term (six to eight hemoglobin were still rising. This same group found that in weeks) control of glucose concentrations in blood (125. 126. a group of diabetic patients being brought into better % 139). Hb A 1 I is widely used as a marker of metabolic control glycemic control, the concentrations of glycated albumin in the diabetic patient, reflecting the effectiveness of the entered the normal range and plateaued. while the concencombined therapy of physical activity, diet, and insulin or trations of glycated hemoglobin were still falling. The other pharmacological agents. The traditional determinaconclusion is that fructosamine is a more responsive marker tion of glucose in blood indicates the status of glucose control of average blood sugar values than is glycated hemoglobin.
• at a given point in time, but only the continuous monitoring Using the TBA assay, Jones et al. (152) noted that prepranr, -of glucose can give an accurate picture of the blood sugar dial blood sugar and fructosamine results decreased by 72ci' % status of a diabetic patient over an extended period. Continand 58%, respectively, after the initiation of therapy in 16J., newly diagnosed diabetic subjects, but Hb A, fell by only fructosamine values are affected by low concentrations of' 391: after eight weeks there were no significant differences albumin and plasma proteins, as in cases of protein-losing in the percentages of decrease of the three parameters. , to three weeks) that can alert the physician to deteriorating had its advantages and disadvantages, and that all provided .ontuol before changes in glvcated hemoglobin can be detectuseful clinical information "if performed properly." Presumed-which may not be apparent for at least four weeks after ably, the same can be said of the various fructosamine improvement of glycemic control (119. 146). In anemia, methods, but a few concluding comments are appropriate. hemolytic or otherwise, marked changes in the life span of
The affinity chromatography and NBT assays are the likely .1 hemoglobin molecules may make glycated hemoglobin valcandidates to become routine procedures. Although many .0. ues unreliable, whereas the blood proteins are relatively studies have been published about the TBA method, it is stable t75). Hemoglobinopathies or recent transfusion can clearly neither as simple nor as rapid as these two, and also adversely affect the usefulness of glycated hemoglobin neither the phenylhydraine derivative nor the furosine values (66 
